Argentum AI signs $4.1B contract for 27,000 Nvidia GB300 GPUs as cloud infrastructure race intensifies
Argentum AI lands a $4.1 billion contract to supply 27,000 Nvidia GB300 GPUs to an unnamed AI company. Meanwhile, Dragos launches EmberAI for OT security, and AWS adds cross-account memory and ephemeral storage for AI workloads.
Argentum AI has signed a $4.1 billion contract to supply approximately 27,000 Nvidia GB300 GPUs to an unnamed leading AI company, with capacity delivery beginning in phases later this year. The deal underscores the relentless demand for dedicated AI cloud infrastructure.
The contract covers long-term access to the GPUs through Argentum's global cloud platform, which spans more than 15 countries either live or contracted. Argentum founder and CEO Andrew Sobko said AI demand continues to outpace infrastructure availability, validating the company's ability to deliver next-generation GPU infrastructure at scale.
AI capacity crunch spurs massive GPU procurement
Argentum's agreement comes as cloud providers and AI companies scramble for compute. The $4.1 billion deal is one of the largest publicly disclosed GPU contracts this year. It follows Argentum's $2.5 billion data center partnership with Boosteroid and DL Invest Group in Poland, where the company will deploy institutional-scale GPU infrastructure within a new 300MW facility.
Other recent developments in the AI infrastructure ecosystem include:
- Dragos launched EmberAI, an AI-powered tool for operational technology cybersecurity, built on its extensive OT threat dataset to help defenders detect and respond to attacks faster.
- AWS introduced cross-account memory access for Amazon Bedrock AgentCore, allowing agents to share memory resources across multiple AWS accounts for more flexible multi-account architectures.
- AWS HealthOmics added ephemeral scratch storage (mounted at /tmp) for private workflows, giving bioinformatics tasks dedicated local space that improves run consistency and reduces costs.
Cloud and security vendors adapt to specialized AI workloads
The new capabilities from AWS and Dragos reflect a broader trend: AI is driving not only massive GPU demand but also a need for more specialized infrastructure services. Cross-account memory in Bedrock lets organizations build complex AI agent systems that span teams, while HealthOmics' scratch storage directly addresses the data-intensive nature of genomic analysis. On the security side, OT environments increasingly require AI-based defenses as industrial systems become more connected.
Argentum's contract and the AWS updates point to an infrastructure market that is bifurcating: hyperscale players invest in general-purpose GPU clouds, while specialists like Argentum and domain-specific services like HealthOmics target particular use cases. The next year will likely see more large GPU deals and tighter integration between AI platforms and the underlying network, storage, and security stack.
Fact check
-
Argentum AI signed a $4.1 billion contract to supply 27,000 Nvidia GB300 GPUs to an unnamed AI company.
reported · source
-
Capacity will be delivered in phases starting later this year.
reported · source
-
Dragos launched EmberAI, an AI tool for operational technology cybersecurity.
reported · source
-
Amazon Bedrock AgentCore Memory now supports cross-account access.
reported · source
-
AWS HealthOmics added ephemeral storage for private workflows.
reported · source
Source reporting (6)
- Data Center Dynamics · Argentum AI secures $4.1bn AI cloud contract with unnamed customer
- SecurityWeek · Dragos Unveils AI for OT Security
- AWS What's New · Amazon Bedrock AgentCore Memory now supports cross-account access
- AWS What's New · AWS HealthOmics now supports ephemeral storage for private workflows
- AWS Machine Learning Blog · Build a protein research copilot with Amazon Bedrock AgentCore
- AWS What's New · Automated Reasoning checks in Amazon Bedrock Guardrails add new policy refinement workflows
Join the conversation
You need to be registered and logged in to comment on blog articles.
0 Comments
No comments yet
Be the first to share your thoughts on this article.